Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nutex Health, Inc. (NUTX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nutex Health, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1479681.
Total stock buying since 2020: $47,907,880,429.
Total stock sales since 2020: $1,601,684.
Total stock option exercises since 2020: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 1,000 | $81,810 | 0 | $0 | 16,516 | $0 |
2024 | 95,703 | $123,343 | 0 | $0 | 66,007 | $0 |
2023 | 2,792,000 | $1,034,476 | 0 | $0 | 86,007 | $0 |
2022 | 0 | $0 | 629,378 | $1,601,684 | 0 | $0 |
2020 | 431,192 | $47,906,640,800 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-04 | 1,000 | $81,810 | 0 | $0 | 0 | $0 |
2025-03 | 0 | $0 | 0 | $0 | 16,516 | $0 |
2024-08 | 3,225 | $62,179 | 0 | $0 | 0 | $0 |
2024-06 | 20,000 | $10,800 | 0 | $0 | 0 | $0 |
2024-05 | 72,478 | $50,364 | 0 | $0 | 0 | $0 |
2024-03 | 0 | $0 | 0 | $0 | 66,007 | $0 |
2023-11 | 640,000 | $148,059 | 0 | $0 | 0 | $0 |
2023-08 | 1,000,000 | $296,032 | 0 | $0 | 0 | $0 |
2023-06 | 102,000 | $43,436 | 0 | $0 | 0 | $0 |
2023-05 | 1,050,000 | $546,949 | 0 | $0 | 0 | $0 |
2023-04 | 0 | $0 | 0 | $0 | 86,007 | $0 |
2022-12 | 0 | $0 | 169,378 | $367,291 | 0 | $0 |
2022-09 | 0 | $0 | 460,000 | $1,234,393 | 0 | $0 |
2020-08 | 126,984 | $2,539,680,000 | 0 | $0 | 0 | $0 |
2020-07 | 228,346 | $41,056,610,800 | 0 | $0 | 0 | $0 |
2020-06 | 75,862 | $4,310,350,000 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-04-08 | Bates Jon Christian (Chief Financial Officer) | Buy | 1,000 | 81.81 | 81,810 |
2025-03-01 | Spears Kelvin (Director) | Option Ex | 143 | .00 | 0 |
2025-03-01 | Detillio Joshua (Chief Operating Officer) | Option Ex | 2,125 | .00 | 0 |
2025-03-01 | Bates Jon Christian (Chief Financial Officer) | Option Ex | 1,611 | .00 | 0 |
2025-03-01 | Vo Thomas T. (Chief Executive Officer) | Option Ex | 5,000 | .00 | 0 |
2025-03-01 | Chang Michael L. (Chief Medical Officer) | Option Ex | 1,250 | .00 | 0 |
2025-03-01 | Montgomery Pamela W. (Chief Legal Officer-Healthcare) | Option Ex | 1,361 | .00 | 0 |
2025-03-01 | Luqman Elisa V (Chief Legal Officer - SEC) | Option Ex | 1,250 | .00 | 0 |
2025-03-01 | Hosseinion Warren (President) | Option Ex | 3,776 | .00 | 0 |
2024-08-22 | Bates Jon Christian (Chief Financial Officer) | Buy | 1,350 | 21.46 | 28,969 |
2024-08-20 | Detillio Joshua (Chief Operating Officer) | Buy | 575 | 17.40 | 10,005 |
2024-08-19 | Detillio Joshua (Chief Operating Officer) | Buy | 1,300 | 17.85 | 23,205 |
2024-06-12 | Detillio Joshua (Chief Operating Officer) | Buy | 20,000 | .54 | 10,800 |
2024-05-30 | Vo Thomas T. (Chief Executive Officer) | Buy | 2,986 | .66 | 1,970 |
2024-05-29 | Vo Thomas T. (Chief Executive Officer) | Buy | 3,768 | .68 | 2,562 |
2024-05-28 | Vo Thomas T. (Chief Executive Officer) | Buy | 48,394 | .70 | 33,875 |
2024-05-13 | Vo Thomas T. (Chief Executive Officer) | Buy | 17,330 | .69 | 11,957 |
2024-03-12 | Bates Jon Christian (Chief Financial Officer) | Option Ex | 49,505 | .00 | 0 |
2024-03-12 | Montgomery Pamela W. (Chief Legal Officer) | Option Ex | 16,502 | .00 | 0 |
2023-11-20 | Vo Thomas T. (Chief Executive Officer) | Buy | 275,200 | .23 | 62,195 |
2023-11-17 | Vo Thomas T. (Chief Executive Officer) | Buy | 224,800 | .23 | 51,704 |
2023-11-15 | Detillio Joshua (Chief Operating Officer) | Buy | 140,000 | .24 | 34,160 |
2023-08-31 | Vo Thomas T. (Chief Executive Officer) | Buy | 152,326 | .28 | 42,651 |
2023-08-30 | Vo Thomas T. (Chief Executive Officer) | Buy | 305,947 | .31 | 94,843 |
2023-08-29 | Vo Thomas T. (Chief Executive Officer) | Buy | 342,744 | .30 | 102,823 |
2023-08-28 | Vo Thomas T. (Chief Executive Officer) | Buy | 198,983 | .28 | 55,715 |
2023-06-15 | Bates Jon Christian (Chief Financial Officer) | Buy | 20,000 | .42 | 8,340 |
2023-06-14 | Montgomery Pamela W. (Chief Legal Officer) | Buy | 12,000 | .43 | 5,136 |
2023-06-14 | Creem Mitchell (Director) | Buy | 50,000 | .43 | 21,400 |
2023-06-13 | Reed Michael Lee (Director) | Buy | 10,000 | .43 | 4,260 |
2023-06-13 | Grenas Cheryl Yvonne (Director) | Buy | 10,000 | .43 | 4,300 |
2023-05-26 | Vo Thomas T. (Chief Executive Officer) | Buy | 18,028 | .49 | 8,833 |
2023-05-25 | Vo Thomas T. (Chief Executive Officer) | Buy | 482,088 | .49 | 236,223 |
2023-05-19 | Vo Thomas T. (Chief Executive Officer) | Buy | 385,000 | .58 | 223,299 |
2023-05-18 | Vo Thomas T. (Chief Executive Officer) | Buy | 114,884 | .48 | 55,144 |
2023-05-18 | Waters John J (Director) | Buy | 50,000 | .47 | 23,450 |
2023-04-01 | Bates Jon Christian (Chief Financial Officer) | Option Ex | 69,505 | .00 | 0 |
2023-04-01 | Montgomery Pamela W. (Chief Legal Officer) | Option Ex | 16,502 | .00 | 0 |
2022-12-13 | Young Matthew Stephen (Director) | Sale | 43,880 | 2.06 | 90,568 |
2022-12-12 | Young Matthew Stephen (Director) | Sale | 125,498 | 2.21 | 276,723 |
2022-09-15 | Bowen Michael (Retired CFO) | Sale | 9,517 | 2.40 | 22,840 |
2022-09-15 | Hosseinion Warren (President) | Sale | 70,000 | 2.36 | 165,200 |
2022-09-14 | Bowen Michael (Retired CFO) | Sale | 483 | 2.60 | 1,253 |
2022-09-14 | Hosseinion Warren (President) | Sale | 130,000 | 2.46 | 319,800 |
2022-09-09 | Hosseinion Warren (President) | Sale | 150,000 | 2.84 | 426,300 |
2022-09-07 | Hosseinion Warren (President) | Sale | 100,000 | 2.99 | 299,000 |
2020-08-12 | Breslin Terence Martin (Director) | Buy | 31,746 | 20,000.00 | 634,920,000 |
2020-08-12 | Meiri David (Director) | Buy | 31,746 | 20,000.00 | 634,920,000 |
2020-08-12 | Creem Mitchell (Director) | Buy | 31,746 | 20,000.00 | 634,920,000 |
2020-08-12 | Waters John J (Director) | Buy | 31,746 | 20,000.00 | 634,920,000 |
2020-07-13 | Margolin Jacob (Director) | Buy | 228,346 | 179,800.00 | 41,056,610,800 |
2020-06-30 | Schimmel Lawrence (Chief Executive Officer) | Buy | 44,828 | 65,000.00 | 2,913,820,000 |
2020-06-30 | Margolin Jacob (Director) | Buy | 31,034 | 45,000.00 | 1,396,530,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NUTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nutex Health, Inc. (symbol NUTX, CIK number 1479681) see the Securities and Exchange Commission (SEC) website.